12th International Tumor Microenvironment Workshop May 2, 2010

Abstract by David Blakey,Chief Scientist AZ, Steve Coats and ChingChing Leow will be presented on the identification of a human antibody that inhibits ang2 function leading to significant anti-tumor activity, both alone and in combination with VEGF inhibitors and cytotoxic drugs.